Lauren Schaeffer
Family · Beaumont, TXNPI 1609508084
Payments from drug & device makers
Across 328 payments — averaging $20.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$2K
- Sanofi$711
- UCB, Inc.$439
- Regeneron Healthcare Solutions, Inc.$277
- Galderma Laboratories, L.p.$253
- plus $2K from 21 others
What the payments were for
- Food & beverage$6,49996%
- Education$2414%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 104 | $1,872 |
| Johnson & Johnson | 51 | $1,523 |
| Sanofi | 33 | $711 |
| UCB, Inc. | 14 | $439 |
| Regeneron Healthcare Solutions, Inc. | 10 | $277 |
| Galderma Laboratories, L.p. | 25 | $253 |
| Sun Pharmaceutical Industries Inc. | 5 | $237 |
| Novartis | 10 | $177 |
| Amgen | 8 | $163 |
| E.r. Squibb & Sons, L.L.C. | 8 | $149 |
| Organon | 17 | $131 |
| Boehringer Ingelheim | 7 | $127 |
| Arcutis Biotherapeutics, Inc. | 6 | $114 |
| Incyte Corporation | 4 | $105 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 5 | $85 |
| Almirall LLC | 3 | $51 |
| Lilly USA, LLC | 2 | $47 |
| Dermavant Sciences, Inc. | 2 | $44 |
| Pfizer | 2 | $34 |
| Sandoz | 2 | $34 |
| LEO Pharma Inc. | 2 | $33 |
| Botanix SB Inc | 2 | $33 |
| Verrica Pharmaceuticals Inc. | 2 | $32 |
| Krystal Biotech Inc | 1 | $23 |
| Genentech USA, Inc. | 1 | $19 |
| LNHC, Inc | 1 | $15 |
| Kerecis Limited | 1 | $13 |
How this compares
$6,741 in reported general payments places this provider in the 95th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 15 | $70,983 |
Paid to pharmacies, not to this prescriber.
Other family in Beaumont
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.